Holen Sie sich die Stockscreener-App
1.03
3.74%
-0.04
Schlusskurs vom Vortag:
$1.07
Offen:
$1.08
24-Stunden-Volumen:
97,850
Relative Volume:
1.42
Marktkapitalisierung:
$17.19M
Einnahmen:
$361.85M
Nettoeinkommen (Verlust:
$-497.76M
KGV:
-0.0528
EPS:
-19.496
Netto-Cashflow:
$-138.60M
1W Leistung:
-9.65%
1M Leistung:
-19.22%
6M Leistung:
-72.82%
1J Leistung:
-86.71%
1-Tages-Spanne:
$1.02
$1.1103
1-Wochen-Bereich:
$1.02
$1.19
52-Wochen-Spanne:
$1.00
$8.75
Gohealth Inc Stock (GOCO) Company Profile
Firmenname
Gohealth Inc
Sektor
Branche
Telefon
(312) 386-8200
Adresse
222 W MERCHANDISE MART PLAZA, CHICAGO
Compare GOCO vs MRSH, AON, AJG, WTW, BRO
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOCO
Gohealth Inc
|
1.03 | 17.19M | 361.85M | -497.76M | -138.60M | -19.50 |
MRSH
Marsh
|
167.27 | 80.59B | 27.55B | 4.01B | 4.93B | 7.9922 |
AON
Aon Plc
|
314.55 | 67.18B | 17.57B | 4.01B | 3.50B | 18.22 |
AJG
Arthur J Gallagher Co
|
205.80 | 52.88B | 14.97B | 1.62B | 1.79B | 6.1922 |
WTW
Willis Towers Watson Public Limited Co
|
259.47 | 24.51B | 9.90B | 1.68B | 1.57B | 17.08 |
BRO
Brown Brown Inc
|
57.51 | 19.49B | 6.40B | 1.15B | 1.43B | 3.1053 |
Gohealth Inc Stock (GOCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-19 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Underperform |
| 2022-03-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | Truist | Buy → Hold |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-11-09 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-12 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2021-08-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-08-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-10-02 | Eingeleitet | Raymond James | Outperform |
| 2020-08-11 | Eingeleitet | William Blair | Outperform |
| 2020-08-10 | Eingeleitet | Barclays | Overweight |
| 2020-08-10 | Eingeleitet | BofA Securities | Buy |
| 2020-08-10 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2020-08-10 | Eingeleitet | Credit Suisse | Outperform |
| 2020-08-10 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Gohealth Inc Aktie (GOCO) Neueste Nachrichten
Analysts Estimate GoHealth (GOCO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
[DEF 14A] GoHealth, Inc. Definitive Proxy Statement - Stock Titan
GoHealth (GOCO) price target decreased by 13.33% to 4.97 - MSN
GOHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against GoHealth, Inc.GOCO - TMX Newsfile
GoHealth (GOCO) Stock Risk | Q4 2025: EPS Misses EstimatesMacro Risk - UBND thành phố Hải Phòng
GoHealth (GOCO) Stock: Market Pressure Analysis | Q4 2025: Earnings Fall ShortGeographic Diversification - Xã Thanh Hà
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth Inc. - GlobeNewswire Inc.
GoHealth Reports Third Quarter 2021 Results - ADVFN
Notification That Annual Report Will Be Submitted Late (nt 10-k) - ADVFN
Statement of Ownership (sc 13g) - ADVFN
GoHealth Announces Preliminary Fourth Quarter and Year End 2021 Results - ADVFN
Quarterly Report (10-q) - ADVFN
Statement of Changes in Beneficial Ownership (4) - ADVFN
GoHealth Reports First Quarter 2023 Results - ADVFN
Annual Report (10-k) - ADVFN
Form 8-KCurrent report - ADVFN
GoHealth Reports Second Quarter 2024 Results - ADVFN
GoHealth (GOCO) price target decreased by 23.73% to 5.74 - MSN
GoHealth Prioritizes Retention and Durability Over Volume in Medicare Advantage Market - citybuzz -
GoHealth puts retention first as a $925M commission asset stays in focus - Stock Titan
GoHealth (GOCO) Stock Faces Resistance Test (Smart Money Active) 2026-04-15Watchlist - Xã Thanh Hà
How The GoHealth (GOCO) Narrative Is Shifting After Target Reset And Nasdaq Compliance Risks - Yahoo Finance
Market Wrap: Is GoHealth Inc stock a good pick for beginners2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
GoHealth, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Market Leaders: Is GoHealth Inc stock overvalued or fairly priced2026 EndofMonth & Expert Curated Trade Setup Alerts - baoquankhu1.vn
GoHealth Reports First Quarter 2025 Results - ADVFN
GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results - ADVFN
MACD Signal: Is GoHealth Inc stock heavily shortedWeekly Trend Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
GoHealth, Inc. (NASDAQ:GOCO) Receives $5.00 Average Price Target from Brokerages - Defense World
Should I Hold GoHealth (GOCO) Stock Now | Price at $1.15, Down 0.86%Expert Entry Points - Xã Thanh Hà
Energy Moves: How does GoHealth Inc perform in inflationary periodsQuarterly Earnings Report & High Conviction Trade Alerts - baoquankhu1.vn
GoHealth (NASDAQ:GOCO) Stock Rating Lowered by Freedom Capital - Defense World
Short Covering: Is GoHealth Inc gaining market share2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
GoHealth stock downgraded to Hold at Freedom Broker on revenue drop - Investing.com Canada
GoHealth stock downgraded to Hold at Freedom Broker on revenue drop By Investing.com - Investing.com South Africa
GoHealth (GOCO) Reports FY2025 Results: EPS $(20.17), Revenue $3 - GuruFocus
Noble Financial Upgrades GoHealth (NASDAQ:GOCO) to Strong-Buy - Defense World
GOCO PE Ratio & Valuation, Is GOCO Overvalued - Intellectia AI
GoHealth, Inc. (GOCO) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
GoHealth (GOCO) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
GoHealth (GOCO) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
GOCO | GoHealth, Inc. Class A FinancialsIncome Statement - Quiver Quantitative
GoHealth: Q4 Earnings Snapshot - marketscreener.com
GoHealth Inc. (GOCO) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
GoHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Liquidity strain and Medicare headwinds at GoHealth (NASDAQ: GOCO) outlined - stocktitan.net
GoHealth, Inc. Reports Year-End Financial Results Highlighting Strategic Adjustments and Focus on Consumer-Centric Initiatives - Quiver Quantitative
Steep revenue decline drives 2025 loss at GoHealth (NASDAQ: GOCO) - Stock Titan
Press Release: GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results - 富途牛牛
Weekly Earnings: Can GoHealth Inc deliver consistent EPS growth2026 Valuation Update & Growth Oriented Trade Recommendations - baoquankhu1.vn
Gohealth Inc expected to post a loss of $1.12 a shareEarnings Preview - TradingView
Finanzdaten der Gohealth Inc-Aktie (GOCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.19%
1.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):